O-DESISOPROPYL O-DESPHENYL SOFOSBUVIR (25 mg) (N-[(2′R)-2′-Deoxy-2′-fluoro-2′-methyl-5′-uridylyl]-L-alanine )

In Stock

Ready to ship

Catalogue No.

1A14160

CAS No.

1233335-78-8

Molecular Formula

C₁₃H₁₉FN₃O₉P

Product Type

Pharmaceutical Analytical Impurities

$0.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F287F0

CAS RN®

1233335-78-8

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₃H₁₉FN₃O₉P

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F287F0	1A14160-F287F0	See Product Information Sheet	India	Chemical Synthesis


Lot No F287F0	USP Certificates/Product Information Sheets and Valid Use Dates 1A14160-F287F0
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* Chemical Synthesis

Lot No

F287F0

USP Certificates/Product Information Sheets and Valid Use Dates

1A14160-F287F0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Got any Queries?

We value your curiosity and strive to provide you with all the information you need. If you have any questions or need further details about our products/services, company, or any other topic related to our website, feel free to reach out to us. Our team is here to assist you promptly.

3’,5’-O,O-DIPHOSPHORYL SOFOSBUVIR (10 mg) (Isopropyl [(S)-{[(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-2-({[{[1-isopropoxy-1-oxopropan-2-yl]amino}(phenoxy)phosphoryl]oxy}methyl)-4-methyltetrahydrofuran-3-yl]oxy}(phenoxy)phosphoryl]-L-alaninate)

FLUTICASONE FUROATE (100 mg) ((6α,11β,16α,17α)-6,9-Difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl 2-furoate)

CARIPRAZINE AMINE DIHYDROCHLORIDE (25 mg) ((1r,4r)-4-{2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]ethyl}cyclohexan-1-amine dihydrochloride )

cis-ISOTERBINAFINE HYDROCHLORIDE (25 mg) ((Z)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine Hydrochloride)

O-DESISOPROPYL O-DESPHENYL SOFOSBUVIR (25 mg) (N-[(2′R)-2′-Deoxy-2′-fluoro-2′-methyl-5′-uridylyl]-L-alanine )

3,4-O-4-ANISYLIDENE CLINDAMYCIN PALMITATE (25 mg) ((3aS,4R,6R,7R,7aS)-4-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-2-(4-methoxyphenyl)-6-(methylthio)tetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-7-yl palmitate)

VORTIOXETINE 3,4-ISOMER HYDROCHLORIDE (25 mg) (1-{2-[(3,4-Dimethylphenyl)thio]phenyl}piperazine hydrochloride)

DESPIPERAZINYL NINTEDANIB (25 mg) (Methyl (Z)-3-{[(4-(methylamino)phenyl)amino](phenyl)methylene}-2-oxoindoline-6-carboxylate)

6-DEHYDRO ESTRADIOL 17-VALERATE (25 mg) ((17β)-3-Hydroxyestra-1,3,5(10),6-tetraen-17-yl valerate)

EDOXABAN PYRIDINE N-OXIDE (25 mg) (5-Chloro-2-(2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetamido)pyridine 1-oxide)